Multimedia

Tuesday, September 24, 2013

Hope for Ovarian Cancer Patients Worldwide: Roswell Park Cancer Institute (RPCI) recently received some exciting news that could lead to new, potentially more effective treatments for patients. The National Cancer Institute (NCI) has awarded one of our research teams with a prestigious Specialized Program of Research Excellence (SPORE) grant in ovarian cancer.

Thursday, August 29, 2013

Sidney Lumet, the director of such fine films as “12 Angry Men” and “Dog Day Afternoon,” once said, “All good work requires self-revelation.” While making good on our commitments to the patients we serve may not seem similar to making a movie, there are commonalities, and Mr. Lumet’s quote definitely applies for us.

Grace Dy, MD, and a patient discuss personalized lung cancer care at RPCI during this radio spot airing on 97 Rock in Buffalo, NY.

Wednesday, July 24, 2013

Country 106.5 WYRK-FM was on hand Wednesday, July 24, to help RPCI celebrate Employee Appreciation Day in Kaminski Park.

Thursday, July 25, 2013

Saying Thank You in Many Different Ways: Gracias. Merci. Danke. Grazie. Dziekuje. Arigato. Xie xie. Asante. From Spanish to Swahili, these are just eight different ways we can say “thank you” to the thousands of people, like you, who are helping us this year to find cures and save lives in our fight against cancer.

Friday, June 28, 2013

The field of immunotherapy traces its origins to the theories of a pioneering American surgeon, William Coley, in the late 19th century but has hit its stride only in the last decade. Though they cover a breadth of different approaches, targets and biological agents, all immunotherapies have this in common: they enlist the body’s own defense program, the immune system, in destroying, controlling and even preventing cancer. Tumor vaccines are one example of such immunotherapy. The most encouraging tumor vaccines used to treat active cancer consist of a patient’s own immune cells, armed to recognize that patient’s cancer and to kill it as well as to stimulate other immune cells to do the same. Such vaccines appear to spare the patient the collateral damage and unpleasant side effects associated with traditional cancer therapies.